Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study

Abstract Cytochrome P450 drug-metabolizing enzymes may contribute to interindividual differences in antidepressant outcomes. We investigated the effects of CYP2C19 and CYP2D6 gene variants on response, tolerability, and serum concentrations. Patients (N = 178) were treated with escitalopram (ESC) fr...

Full description

Bibliographic Details
Main Authors:	Farhana Islam, Victoria S. Marshe, Leen Magarbeh, Benicio N. Frey, Roumen V. Milev, Claudio N. Soares, Sagar V. Parikh, Franca Placenza, Stephen C. Strother, Stefanie Hassel, Valerie H. Taylor, Francesco Leri, Pierre Blier, Rudolf Uher, Faranak Farzan, Raymond W. Lam, Gustavo Turecki, Jane A. Foster, Susan Rotzinger, Sidney H. Kennedy, Daniel J. Müller
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-09-01
Series:	Translational Psychiatry
Online Access:	https://doi.org/10.1038/s41398-022-02124-4

Similar Items

Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
by: Sophie R. Vaccarino, et al.
Published: (2024-01-01)

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
by: Caroline W. Espinola, et al.
Published: (2022-05-01)

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
by: Jacqueline K. Harris, et al.
Published: (2022-01-01)

CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression
by: Rodrigo Bernini de Brito, et al.
Published: (2020-05-01)

Population pharmacokinetics model for escitalopram in Chinese psychiatric patients: effect of CYP2C19 and age
by: Shujing Liu, et al.
Published: (2022-07-01)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
by: Stacey L. Aldrich, et al.
Published: (2019-02-01)

CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population
by: Xinyi Huang, et al.
Published: (2021-08-01)

Alterations in the neural correlates of affective inhibitory control following cognitive behavioral therapy for depression: A Canadian biomarker integration network for depression (CAN-BIND) study
by: Prabhjot Dhami, et al.
Published: (2022-12-01)

Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study
by: Mahmood Mahajna, et al.
Published: (2023-12-01)

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
by: Anastasiya Slyepchenko, et al.
Published: (2023-09-01)

A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol
by: Jennifer L. Phillips, et al.
Published: (2020-06-01)

Polymorphisms in the cytochrome <it>P</it>450 genes <it>CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1</it>, <it>CYP19A1 </it>and colorectal cancer risk
by: Withey Laura, et al.
Published: (2007-07-01)

In vitro and In silico studies of interactions of cathinone with human recombinant cytochrome P450 CYP(1A2), CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2, and CYP3A5
by: Sharoen Yu Ming Lim, et al.
Published: (2022-01-01)

Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report
by: Jianhong Wu, et al.
Published: (2023-10-01)

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
by: Mirza Bojić, et al.
Published: (2019-09-01)

Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
by: Benjamin Schwartzmann, et al.
Published: (2023-05-01)

Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula
by: Francesco Carano, et al.
Published: (2018-01-01)

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
by: Denisenko NP, et al.
Published: (2018-06-01)

MD Investigation on the Interaction between Carbamazepine and Two CYP Isoforms, CYP3A4 and CYP3A5
by: Shuhui Liu, et al.
Published: (2023-01-01)

<it>CYP3A4 </it>and <it>CYP3A5 </it>genotyping by Pyrosequencing
by: McLeod Howard L, et al.
Published: (2005-05-01)

Characterisation of <it>CYP2C8</it>, <it>CYP2C9 </it>and <it>CYP2C19 </it>polymorphisms in a Ghanaian population
by: Dodoo Alexander NO, et al.
Published: (2009-12-01)

In vitro and in silico inhibition performance of choline against CYP1A2, CYP2D6 and CYP3A4
by: Emilio Mateev, et al.
Published: (2022-12-01)

Maternal protein restriction during lactation modulated the expression and activity of rat offspring hepatic CYP1A1, CYP1A2, CYP2B1, CYP2B2, and CYP2E1 during development
by: N. Meireles Da Costa, et al.
Published: (2016-11-01)

Maternal protein restriction during lactation modulated the expression and activity of rat offspring hepatic CYP1A1, CYP1A2, CYP2B1, CYP2B2, and CYP2E1 during development
by: N. Meireles Da Costa, et al.

Methodology for clinical genotyping of CYP2D6 and CYP2C19
by: Beatriz Carvalho Henriques, et al.
Published: (2021-11-01)

Investigation of cytochrome p450 CYP1A2, CYP2D6, CYP2E1 and CYP3A4 gene expressions and polymorphisms in alcohol withdrawal (eng)
by: Nazife Taşçıoğlu, et al.
Published: (2021-09-01)

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates
by: Miriam Saiz-Rodríguez, et al.
Published: (2020-04-01)

Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations
by: Sara Flores-Gutiérrez, et al.
Published: (2017-02-01)

Preferential expression of cytochrome CYP CYP2R1 but not CYP1B1 in human cord blood hematopoietic stem and progenitor cells
by: Shuoqi Xu, et al.
Published: (2014-12-01)

Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report
by: Giorgia Caspani, et al.
Published: (2021-07-01)

Evaluation of Drug–Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor
by: Jim J. Xiao, et al.
Published: (2019-01-01)

Rhythmicity of sleep and clinical outcomes in major depressive disorder: A CAN-BIND-1 report
by: Manish Dama, et al.
Published: (2022-07-01)

Understanding inter-individual variability in pharmacokinetics/pharmacodynamics of aripiprazole in children with tic disorders: Individualized administration based on physiological development and CYP2D6 genotypes
by: Yingying Xin, et al.
Published: (2022-12-01)

Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19
by: Beatriz Carvalho Henriques, et al.
Published: (2022-03-01)

Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers
by: Yousef M. Al-saraireh, et al.
Published: (2021-03-01)

Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism
by: Vera Dias, et al.
Published: (2011-01-01)

Expression and activities of hepatic cytochrome P450 (CYP1A, CYP2A and CYP2E1) in entire and castrated male pigs
by: C. Brunius, et al.
Published: (2012-01-01)

The Evaluation of <i>CYP2D6, CYP2C9, CYP2C19</i>, and <i>CYP2B6</i> Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics
by: Arianna Giorgetti, et al.
Published: (2023-05-01)

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response
by: Laura M. Fiori, et al.
Published: (2021-08-01)

Altered Protein Expression of Cardiac CYP2J and Hepatic CYP2C, CYP4A, and CYP4F in a Mouse Model of Type II Diabetes—A Link in the Onset and Development of Cardiovascular Disease?
by: Benoit Drolet, et al.
Published: (2017-10-01)